Evidence map›Paper›PMID 36360904›Full record

ArticleInternational journal of environmental research and public health2022

HLA Genotypes in Patients with Infection Caused by Different Strains of SARS-CoV-2.

Ludmila Bubnova, Irina Pavlova, Maria Terentieva, Tatiana Glazanova, Elena Belyaeva, Sergei Sidorkevich, Nataliya Bashketova, Irina Chkhingeria, Mal'vina Kozhemyakina, Daniil Azarov and 6 more

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Ludmila BubnovaRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.
Irina PavlovaRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.
Maria TerentievaRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.
Tatiana GlazanovaRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.ORCID 0000-0002-1022-8127
Elena BelyaevaRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.
Sergei SidorkevichRussian Research Institute of Hematology and Transfusion Science, FMBA, 191024 St. Petersburg, Russia.
Nataliya BashketovaSaint Petersburg Office, Federal Service for Consumer Rights Protection and Human Welfare, 191025 St. Petersburg, Russia.
Irina ChkhingeriaSaint Petersburg Office, Federal Service for Consumer Rights Protection and Human Welfare, 191025 St. Petersburg, Russia.
Mal'vina KozhemyakinaSaint Petersburg Center for Hygiene and Epidemiology, 191023 St. Petersburg, Russia.
Daniil AzarovSaint Petersburg Center for Hygiene and Epidemiology, 191023 St. Petersburg, Russia.
Raisa KuznetsovaDepartment of immunology, Faculty of medicine, Pavlov First Saint Petersburg State Medical University, Russian Ministry of Health, 197022 St. Petersburg, Russia.
Edward S RamsaySaint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia.
Anna GladkikhSaint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia.ORCID 0000-0001-6759-1907
Alena SharovaSaint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia.ORCID 0000-0003-2086-7480
Vladimir DedkovSaint Petersburg Pasteur Research Institute of Epidemiology and Microbiology, 197101 St. Petersburg, Russia.ORCID 0000-0002-5500-0169
Areg TotolianDepartment of immunology, Faculty of medicine, Pavlov First Saint Petersburg State Medical University, Russian Ministry of Health, 197022 St. Petersburg, Russia.ORCID 0000-0003-4571-8799

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aggressive infectious nature of SARS-CoV-2, its rapid spread, and the emergence of mutations necessitate investigation of factors contributing to differences in SARS-CoV-2 susceptibility and severity. The role of genetic variations in the human HLA continues to be studied in various populations in terms of both its effect on morbidity and clinical manifestation of illness. The study included 484 COVID-19 convalescents (northwest Russia residents of St. Petersburg). Cases in which the responsible strain was determined were divided in two subgroups: group 1 (

Indexed as

COVID-19SARS-CoV-2GenotypeHLA-A AntigensHumansHLA-A AntigensCOVID-19HLAnorthwestern federal districtRussiavariants of concern

Identifiers

PMID36360904
PMCPMC9657774

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.